Open Access

Closing remarks - Exploring vascular protection in patients with CAD or PAD through the potential of factor Xa inhibition... The COMPASS study.

Presentation

About the speaker

Doctor Stuart J Connolly

Population Health Research Institute, McMaster University, Hamilton (Canada)
10 presentations
0 follower

3 more presentations in this session

Opening remarks - Exploring vascular protection in patients with CAD or PAD through the potential of factor Xa inhibition... The COMPASS study.

Speaker: Doctor S. Yusuf (Hamilton, CA)

Thumbnail

Which patients with CAD or PAD are at the highest risk of cardiovascular events... What do the registries teach us.

Speaker: Professor P. Steg (Paris, FR) Professor D. Bhatt (Boston, US)

Thumbnail

The COMPASS study... Vascular protection with rivaroxaban in patients with CAD or PAD.

Speaker: Doctor S. Connolly (Hamilton, CA) Doctor J. Eikelboom (Hamilton, CA)

Thumbnail

Access the full session

Exploring vascular protection in patients with coronary artery disease (CAD) or peripheral artery disease (PAD) through the potential of factor Xa inhibition... The COMPASS study

Speakers: Doctor S. Connolly, Doctor S. Yusuf, Professor P. Steg, Professor D. Bhatt, Doctor S. Connolly...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk